Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes

Despite extensive research, the functions of the basal ganglia (BG) in movement control have not been fully understood. Eye movements, particularly saccades, are convenient indicators of BG function. Here, we review the main oculomotor findings reported in Parkinson’s disease (PD) and genetic parkinsonian syndromes. PD is a progressive, neurodegenerative disorder caused by dopaminergic cell loss within the substantia nigra pars compacta, resulting in depletion of striatal dopamine and subsequent increased inhibitory BG output from the internal globus pallidus and the substantia nigra pars reticulata. Eye movement abnormalities are common in PD: anomalies are more evident in voluntary than reflexive saccades in the initial stages, but visually guided saccades may also be involved at later stages. Saccadic hypometria (including abnormally fragmented saccades), reduced accuracy, and increased latency are among the most prominent deficits. PD patients show also unusually frequent and large square wave jerks and impaired inhibition of reflexive saccades when voluntary mirror saccades are required. Poor convergence ability and altered pursuit are common. Inherited parkinsonisms are a heterogeneous group of rare syndromes due to gene mutations causing symptoms resembling those of PD. Eye movement characteristics of some parkinsonisms have been studied. While sharing some PD features, each syndrome has a distinctive profile that could contribute to better define the clinical phenotype of parkinsonian disorders. Moreover, because the pathogenesis and the underlying neural circuit failure of inherited parkinsonisms are often well defined, they might offer a better prospect than idiopathic PD to understand the BG function.

[1]  R. Leigh,et al.  Tremor of the Eyes, or of the Head, in Parkinson's Disease? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[2]  A. Lees,et al.  Visual dysfunction in Parkinson’s disease , 2016, Brain : a journal of neurology.

[3]  Y. J. Liao,et al.  Abnormal eye movement behavior during reading in Parkinson's disease. , 2016, Parkinsonism & related disorders.

[4]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[5]  O. Levy,et al.  The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[6]  K. Fukushima,et al.  Clinical application of eye movement tasks as an aid to understanding Parkinson’s disease pathophysiology , 2017, Experimental Brain Research.

[7]  B. Gaymard Cortical and sub-cortical control of saccades and clinical application. , 2012, Revue neurologique.

[8]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[9]  O. Hikosaka,et al.  New perspectives on the pathophysiology of Parkinson’s disease as assessed by saccade performance: A clinical review , 2013, Clinical Neurophysiology.

[10]  Philip L De Jager,et al.  Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.

[11]  P. Calabresi,et al.  Direct and indirect pathways of basal ganglia: a critical reappraisal , 2014, Nature Neuroscience.

[12]  J. Deakin,et al.  Cognition and the inhibitory control of saccades in schizophrenia and Parkinson's disease. , 2002, Progress in brain research.

[13]  M G Saslow,et al.  Latency for saccadic eye movement. , 1967, Journal of the Optical Society of America.

[14]  T. Mergner,et al.  What is pathological with gaze shift fragmentation in Parkinson's disease? , 2002, Journal of Neurology.

[15]  F. Binkofski,et al.  Clinical spectrum of Kufor‐Rakeb syndrome in the Chilean kindred with ATP13A2 mutations , 2010, Movement disorders : official journal of the Movement Disorder Society.

[16]  D. Kömpf,et al.  Different saccadic abnormalities in PINK1 mutation carriers and in patients with non-genetic Parkinson’s disease , 2009, Journal of Neurology.

[17]  Tim Anderson,et al.  Don’t look now or look away: Two sources of saccadic disinhibition in Parkinson's disease? , 2008, Neuropsychologia.

[18]  J. Sweeney,et al.  Pharmacological treatment effects on eye movement control , 2008, Brain and Cognition.

[19]  M. Koenig,et al.  Ophthalmic features of PLA2G6-related paediatric neurodegeneration with brain iron accumulation , 2014, British Journal of Ophthalmology.

[20]  R. Schiffmann,et al.  The Saccadic and Neurological Deficits in Type 3 Gaucher Disease , 2011, PloS one.

[21]  S. Lindquist,et al.  α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity , 2009, Nature Genetics.

[22]  G. Mankekar,et al.  Clinical Features and Diagnosis , 2014 .

[23]  M. Repka,et al.  Ocular motor and sensory function in Parkinson's disease. , 2012, Ophthalmology.

[24]  C Kennard,et al.  Oculomotor abnormalities in diseases of the basal ganglia. , 1989, Revue neurologique.

[25]  K. Marder,et al.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.

[26]  A. Lees,et al.  Kufor Rakeb Disease: Autosomal recessive, levodopa‐responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.

[27]  P. May The mammalian superior colliculus: laminar structure and connections. , 2006, Progress in brain research.

[28]  Thomas Wichmann,et al.  Update on models of basal ganglia function and dysfunction. , 2009, Parkinsonism & related disorders.

[29]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[30]  Paul A Wetzel,et al.  Pervasive ocular tremor in patients with Parkinson disease. , 2012, Archives of neurology.

[31]  Richard D. Jones,et al.  Adaptive modification of saccade amplitude in Parkinson's disease. , 2002, Brain : a journal of neurology.

[32]  H. Shibasaki,et al.  Oculomotor abnormalities in Parkinson's disease. , 1979, Archives of neurology.

[33]  B. Oostra,et al.  Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. , 2012, American journal of human genetics.

[34]  O. Hikosaka Basal Ganglia Mechanisms of Reward‐Oriented Eye Movement , 2007, Annals of the New York Academy of Sciences.

[35]  D. Munoz,et al.  Probing basal ganglia functions by saccade eye movements , 2011, The European journal of neuroscience.

[36]  J. Jankovic Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[37]  W. Heide,et al.  Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD , 2010, Neurology.

[38]  A Beuter,et al.  Fluctuations in tremor at rest and eye movements during ocular fixation in subjects with Parkinson's disease. , 1998, Parkinsonism & related disorders.

[39]  C. Harris,et al.  Ocular motor abnormalities in Gaucher disease. , 1999, Neuropediatrics.

[40]  A. Srivastava,et al.  Saccadic eye movements in Parkinson's disease , 2014, Indian journal of ophthalmology.

[41]  Jan Kassubek,et al.  Alterations of Eye Movement Control in Neurodegenerative Movement Disorders , 2014, Journal of ophthalmology.

[42]  Soma Das,et al.  Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). , 2005, American journal of ophthalmology.

[43]  Elias Provencio-Vasquez,et al.  A decade in review , 2010 .

[44]  R. Hanajima,et al.  Small saccades restrict visual scanning area in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[45]  K. Marder,et al.  Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.

[46]  Thomas Wichmann,et al.  Circuits and circuit disorders of the basal ganglia. , 2007, Archives of neurology.

[47]  C. Helmchen,et al.  Blink amplitude but not saccadic hypometria indicates carriers of Parkin mutations , 2006, Journal of Neurology.

[48]  Wei Zheng,et al.  Manganese Toxicity Upon Overexposure: a Decade in Review , 2015, Current Environmental Health Reports.

[49]  L. Optican,et al.  Eye movements in genetic parkinsonisms affecting the α-synuclein, PARK9, and manganese network , 2017, Clinical Neurophysiology.

[50]  Antisaccades in Parkinson disease , 2017, Neurology.

[51]  E. Bézard,et al.  Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms , 2009, The Lancet Neurology.

[52]  A. Sprenger,et al.  Eye movement disorders in ATP13A2 mutation carriers (PARK9) , 2010, Movement disorders : official journal of the Movement Disorder Society.

[53]  C. Kennard,et al.  Antisaccades and executive dysfunction in early drug‐naive Parkinson's disease: The discovery study , 2015, Movement disorders : official journal of the Movement Disorder Society.

[54]  R. Tomlinson,et al.  Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. , 1983, Brain : a journal of neurology.

[55]  D. Buckwell,et al.  Ocular Tremor in Parkinson's Disease Is Due to Head Oscillation , 2013, Movement disorders : official journal of the Movement Disorder Society.

[56]  L. Optican,et al.  Mechanism of interrupted saccades in patients with late-onset Tay-Sachs disease. , 2008, Progress in brain research.

[57]  Ocular tremor in Parkinson's disease: The debate is not over , 2013, Movement disorders : official journal of the Movement Disorder Society.

[58]  M. Saslow Effects of components of displacement-step stimuli upon latency for saccadic eye movement. , 1967, Journal of the Optical Society of America.

[59]  Julie M. Hall,et al.  Antisaccade errors reveal cognitive control deficits in Parkinson’s disease with freezing of gait , 2015, Journal of Neurology.

[60]  Brian E. Keck A Critical Reappraisal , 2010 .

[61]  T. Anderson,et al.  Eye movements in patients with neurodegenerative disorders , 2013, Nature Reviews Neurology.

[62]  O. Hikosaka,et al.  Role of the basal ganglia in the control of purposive saccadic eye movements. , 2000, Physiological reviews.

[63]  B. Gaymard,et al.  Eye Movements in Ephedrone-Induced Parkinsonism , 2014, PloS one.

[64]  A. Beuter,et al.  Fluctuations in tremor at rest and saccadic eye movements in subjects with Parkinsons disease. , 1997, Parkinsonism & related disorders.

[65]  M. Castelo‐Branco,et al.  Distinct functional properties of the vertical and horizontal saccadic network in Health and Parkinson's disease: An eye-tracking and fMRI study , 2016, Brain Research.

[66]  M. Hallett,et al.  The cerebellum in Parkinson’s disease , 2013, Brain : a journal of neurology.

[67]  D. Zee,et al.  ‘Staircase’ square-wave jerks in early Parkinson's disease , 2010, British Journal of Ophthalmology.

[68]  J. Gnadt,et al.  Activity of omnipause neurons during “staircase saccades” elicited by persistent microstimulation of the superior colliculus , 2006, Vision Research.

[69]  P. Alfonso,et al.  Neurological evaluation of patients with Gaucher disease diagnosed as type 1 , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[70]  M Vidailhet,et al.  Mixing pro- and antisaccades in patients with parkinsonian syndromes. , 2006, Brain : a journal of neurology.

[71]  G. Fraedrich,et al.  Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.

[72]  Tatiana Foroud,et al.  Multiple step pattern as a biomarker in Parkinson disease. , 2009, Parkinsonism & related disorders.

[73]  Masaya Segawa,et al.  Initiation and inhibitory control of saccades with the progression of Parkinson's disease – Changes in three major drives converging on the superior colliculus , 2011, Neuropsychologia.

[74]  R. Armstrong,et al.  Oculo-Visual Dysfunction in Parkinson’s Disease , 2015, Journal of Parkinson's disease.